End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP [Phase 4]
Phase 4 trial evaluating long-term safety and efficacy of Tenapanor alone or with Sevelamer in dialysis patients with hyperphosphatemia and …
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function [Phase 1]
A Phase 1 study evaluating tirzepatide (LY3298176) in participants with impaired kidney function has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia [Phase 2]
Phase 2 trial investigating the effects of patiromer on serum potassium and gut microbiome in patients with end-stage renal disease and hype…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Anti-Cytokine Therapy for Hemodialysis InflammatION [Phase 2]
Phase 2 clinical trial update on an anti-cytokine therapy for inflammation in hemodialysis patients with end-stage renal disease; results po…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients [Phase 4]
Phase 4 trial update assessing pharmacokinetics and dialyzability of dapagliflozin in dialysis patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Vitamin D, Oxidative Stress and Inflammation in Hemodialysis [Phase 2, Phase 3]
A clinical trial update on the effects of vitamin D on oxidative stress and inflammation in patients undergoing hemodialysis, with phase 2 a…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis [Phase 2]
Phase 2 clinical trial evaluating ISIS 416858 given subcutaneously to participants with end-stage renal disease on hemodialysis has been com…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients [NA]
A clinical trial evaluating an immunomodulatory biomimetic device for treating myocardial stunning in patients with end-stage renal disease;…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Colchicine and Inflammation in Hemodialysis Patients [Phase 2]
Phase 2 trial investigating colchicine and inflammation in patients with end-stage renal disease on dialysis.
-
CLINICAL_TRIALS research · 2022-12-12Clinical Trial Update: A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment [NA]
A completed clinical trial evaluating tolerability and efficacy of AKST1210 in patients on hemodialysis with cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Channa Striatus Extract on Albumin and Hs-CRP ESRD [Phase 4]
Phase 4 trial update evaluating Channa Striatus extract on albumin and hs-CRP in end-stage renal disease with inflammation.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Gut Microbiome and p-Inulin in Hemodialysis [NA]
Clinical trial on gut microbiome and p-inulin in hemodialysis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM [Phase 2]
Phase 2 trial update on using metformin prophylaxis to prevent post-transplant diabetes mellitus after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: DIalysis Symptom COntrol-Restless Legs Syndrome Trial [Phase 3]
Phase 3 trial update for a dialysis-related symptom control program targeting Restless Legs Syndrome in patients with End Stage Renal Diseas…
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration [NA]
A terminated clinical trial evaluating intradialytic blood pressure slope-guided ultrafiltration in ESRD patients with extracellular fluid a…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis [Phase 3]
A Phase 3 trial evaluating the effect of vitamin C and E therapy on restless legs syndrome in patients with end-stage renal disease on haemo…
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Does Correction of 25 OH-VITAmin D With Cholecalciferol Supplementation Increase Muscle Strength in hemoDIALysis Patients? [Phase 3]
A Phase 3 clinical trial evaluating whether correcting 25-hydroxy vitamin D with cholecalciferol supplementation improves muscle strength in…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients [NA]
A completed clinical trial comparing three dialyzers for basic performance and hemocompatibility in patients with end stage renal disease.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants [Phase 3]
Phase 3 trial evaluating conversion to roxadustat in hemodialysis patients already on stable ESA or as initial anemia treatment; completed w…
-
FDA approval · 2022-07-20FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Lanthanum carbonate.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis [Phase 2]
Phase 2 clinical trial update for AKB-6548 in anemia associated with end-stage renal disease requiring hemodialysis has completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of ticagrelor to maintain patency of arteriovenous fistulae for hemodialysis; completed with p…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients [Phase 3]
A Phase 3 trial evaluating a reduced-dose rivaroxaban regimen for chronic anticoagulation in end-stage renal disease patients on chronic hem…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Sirolimus Use in Angioplasty for Vascular Access Extension [Phase 2]
Phase 2 trial update on sirolimus use in angioplasty for vascular access extension in end-stage renal disease with venous stenosis.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Ixazomib for Desensitization [Phase 2]
Phase 2 clinical trial evaluating ixazomib for desensitization in kidney disease patients was completed with results posted in 2022.